KONTA CHINA (01312) announced that the group expects to record impairment losses on financial assets under the expected credit loss model of approximately HK$154 million to HK$185 million for the six months ending June 30, 2025; impairment losses on intangible assets of approximately HK$113 million to HK$124 million; and goodwill impairment losses in the fitness business segment of approximately HK$80.4 million to HK$88.8 million.

Due to the impact of the aforementioned expected impairment losses, combined with declining revenue and gross profit in the group's pharmaceutical segment caused by intensified market competition, the group expects to record comprehensive net losses of approximately HK$283 million to HK$346 million for the period, compared to comprehensive net losses of approximately HK$4.5 million for the six months ended June 30, 2024.